禁售傳聞困擾 英偉達A800晶片內地售價飆兩成
內地傳媒報道,AI晶片龍頭英偉達(NVDA.US)於內地市場銷售AI晶片A800近期價格大幅上漲。
英偉達於中國一間代理商稱,考慮到禁售AI晶片的傳聞,大家較為惜售,一個星期以來價格升幅20%至30%。現在英偉達A800晶片一日一個價格,如果購買量多的話,以每片逾10多萬元人民幣(下同)出售,少的話每片售價高於11萬元。目前手上仍有現貨,建議早點買入,預期後期價格將會更高。
報道稱,英偉達2022年三季度推出、專供中國的A800晶片,在無許可證的情況下或將被禁售。
不過,英偉達A800系列晶片原本在中國市場已面臨供應緊缺問題。今年,聯想集團展出配置英偉達A800晶片的高端服務器,該款服務器供應非常緊張,下單後需要10個月才能有貨。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.